The latest market intelligence, insights and interviews covering the cell and gene therapy industry's most pressing challenges, from translation to automation, manufacturing to market access, viral vectors to bioreactors.

Diversity & Inclusion in Advanced Therapies

In this eBook we highlight eight cell and gene therapy companies that are making positive change through diversity and inclusion.

AAV vector manufacturing: Transfection matters

Optimising the transfection process and its efficiency is paramount to boosting vector titres during scale-up and manufacturing of AAV vectors with new generation transfection reagents

Advanced Therapies Manufacturing Capacity in North America

A comprehensive guide showcasing the growing cell and gene therapy and viral vector manufacturing landscape in North America

Exploring Dedicated Donor Paradigms as a Solution to Advanced...

By Dominic Clarke, Global Head of Cell Therapy at HemaCare

Improving the Flexibility and Predictability of CAR-T Manufacturing

Getting CAR-T product pipelines to market faster: saving time, money and improving flexibility and predictability

Technology Review: In-process Analytics for Advanced Therapies

Edition Three of Phacilitate’s technology review series examines in-process analytics tools that will innovate and improve...

Episode 6 David Smith, Akron Biotech and Oliver Ball, Stemmatters

Dave and Oli share their views on what's slowing down cell therapy approval rates

[WEBINAR] Point of Care Manufacturing for Next-Generation Advanced...

On-demand access to a live webinar from 22nd October 2020

Enabling Patient Access to Personalised Cell Therapies Through...

Dr Ohad Karnieli talks to us about point-of-care manufacturing challenges, solid tumour treatments and taking inspiration from....

Episode 5 Women in Advanced Therapies Special with Maria Fardis,...

Maria Fardis and Nicola Ambler talk about TILs, mentorship and the importance of partnering

Survey: Automating Raw Materials Processes in Cell and Gene Therapy...

How are you approaching automation of raw materials processes?

Embedding Flexibility into Automated Bioprocessing

An interview with Sean Werner, President, Sexton Biotechnologies

Episode 4: Women in Advanced Therapies Special with Jeanne Loring,...

Jeanne Loring discusses the struggles facing women in the cell and gene therapy industry

The Thawing Dilemma: Where and How Should We be Thawing Advanced...

A presentation with Joseph Schwartz, MD, MPH, Director, Transfusion Medicine and Cellular Therapy at New York-Presbyterian Hospital and Columbia...

Non-dilutive Funding Sources for Advanced Therapy Biotechs

A comprehensive report examining non-dilutive funding applications that are currently open or opening soon, in partnership with FreeMind

1
2
3
4
5
6
7
8
9
…
next
last